Disposition of 1048 shares by Joel Goldberg of Revvity at 119.48 subject to Rule 16b-3
| RVTY Stock | 116.23 1.16 1.01% |
Slightly above 51% of Revvity's investor base is interested to short. The analysis of overall sentiment of trading Revvity stock suggests that many investors are impartial at this time. Revvity's investing sentiment can be driven by a variety of factors including economic data, Revvity's earnings reports, geopolitical events, and overall market trends.
Revvity |
Filed transaction by Revvity Officer: Please See Remarks. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Revvity Fundamental Analysis
We analyze Revvity's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Revvity using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Revvity based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
Revvity is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Revvity Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Revvity stock to make a market-neutral strategy. Peer analysis of Revvity could also be used in its relative valuation, which is a method of valuing Revvity by comparing valuation metrics with similar companies.
Peers
Revvity Related Equities
| ACRS | Aclaris Therapeutics | 5.23 | ||||
| TWST | Twist Bioscience | 4.27 | ||||
| A | Agilent Technologies | 2.81 | ||||
| WAT | Waters | 2.64 | ||||
| QGEN | Qiagen NV | 1.18 | ||||
| LH | Laboratory | 1.14 | ||||
| MEDP | Medpace Holdings | 1.12 | ||||
| IDXX | IDEXX Laboratories | 1.06 | ||||
| CRL | Charles River | 0.93 | ||||
| MTD | Mettler Toledo | 0.90 | ||||
| ICLR | ICON PLC | 0.33 | ||||
| IQV | IQVIA Holdings | 0.1 | ||||
| NEOG | Neogen | 7.45 |
Additional Tools for Revvity Stock Analysis
When running Revvity's price analysis, check to measure Revvity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revvity is operating at the current time. Most of Revvity's value examination focuses on studying past and present price action to predict the probability of Revvity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revvity's price. Additionally, you may evaluate how the addition of Revvity to your portfolios can decrease your overall portfolio volatility.